HEALTH SCIENCES ACQUISITIONS CORP 2 HSAQ 深 滬
交易中 03-26 10:47:29 美东时间
13.31
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 13.31
- 總市值 1.49亿
- 52周最高 13.80
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 9.41
- 委 比 0.00%
- 總股本 1121.21万
- 歷史最高 14.66
- 量 比 0
- 振 幅 0.00%
- 歷史最低 9.41
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webcast on March 26
Medicus Pharma Ltd. reported positive results from its Phase 2 SKNJCT-003 clinical trial, showing 73% clinical clearance in the 200-µg dose group for nodular basal cell carcinoma, potentially reducing the need for surgery. Dr. Babar K. Rao, a leading dermatologist, will discuss the findings during a webcast on March 26, 2026. The study highlights SkinJect's potential as a non-surgical treatment option.
03-16 11:30
Noveris Health Sciences CEO Joshua Bartch resigns
Noveris Health Sciences (CSE: NVRS) (FSE: 0NF0) (OTC: MYCOF) on Tuesday said that Joshua Bartch has resigned as Director, President and CEO of the company. The company appointed Jason Birmingham, its ...
03-11 04:15
Noveris Health Sciences says JJK subsidiary now holds 3,848,706 shares in the company
Noveris Health Sciences says JJK subsidiary now holds 3,848,706 shares in the company Noveris Health Sciences Inc. reported that the conversion of debentures totaling $8,188,628 resulted in the issuance of 47,687,939 common shares at a conversion price of $0.192682432. Following the conversions and
03-07 08:30
Moomoo and W!se Award $10,000 to Queens Gateway to Health Sciences Secondary School as Part of Student Stock Showdown Challenge
Moomoo and W!se partnered to host the "Student Stock Showdown," a 13-week paper trading competition, recognizing Queens Gateway to Health Sciences Secondary School for its outstanding performance. The program provided students with a simulated investing experience, enhancing financial literacy and critical thinking skills. Queens Gateway received $10,000, while two other schools and individual student winners were awarded for their achievements. ...
02-24 13:00
Usana Health Sciences Q4 Earnings Assessment
Usana Health Sciences (NYSE:USNA) just disclosed its Q4 earnings on Tuesday, Fe...
02-18 05:18
Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board
Cyclerion Therapeutics has received positive regulatory feedback from the FDA for its Phase 2 POC study of CYC-126 for treatment-resistant depression (TRD). CYC-126, an anesthetic-based therapy using real-time EEG feedback, aims to address TRD through individualized, precision delivery. The FDA supports the study design, leveraging approved anesthetics, allowing Cyclerion to remain on track to initiate the trial in late 2026. Additionally, the co...
02-17 12:00
Simulations Plus Extends Research Collaborations with FDA and NIEHS
Simulations Plus Extends Research Collaborations with FDA and NIEHS Simulations Plus Inc. has announced the extension of two research collaborations with the U.S. Food and Drug Administration (FDA) and the National Institute of Environmental Health Sciences (NIEHS). These extended projects aim to ad
02-10 07:45
Simulations Plus verlängert Forschungskooperationen mit FDA und NIEHS
Simulations Plus verlängert Forschungskooperationen mit FDA und NIEHS Simulations Plus Inc. hat die Verlängerung zweier Forschungskooperationen mit der US-amerikanischen Food and Drug Administration (FDA) und dem National Institute of Environmental Health Sciences (NIEHS) bekanntgegeben. Die erweite
02-10 07:45
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
Bionano Genomics宣布将于2026年2月23日至26日举办全球虚拟光学基因组映射(Optical Genome Mapping, OGM) Symposium 2026。该会议旨在展示OGM技术在癌症研究、生物处理、遗传学和基因及细胞治疗等领域的最新进展。会议为期四天，将有来自北美、欧洲和亚洲的30多位研究人员进行演讲，内容涵盖血液恶性肿瘤、实体瘤、生物处理、遗传疾病和基因及细胞治疗等研究应用。会议还包括科学报告、互动小组讨论及问答环节，以及虚拟海报展示。Bionano总裁兼首席执行官Erik Holmlin表示，通过OGM技术，科学家们能够揭示传统技术难以检测的基因组复杂性，凸显OGM在研究中的重要性。会议注册免费，参与者可访问指定链接注册并提交海报。
02-09 14:05
Cognizant Q4 Financial Services Revenue Hits USD 1.59 Billion, Up 10.5%
Cognizant Q4 Financial Services Revenue Hits USD 1.59 Billion, Up 10.5% Cognizant reported fourth quarter (Q4) revenue of USD 5.33 billion, an increase of 4.9% year-over-year. For the full year (FY) 2025, revenue reached USD 21.10 billion, up 7.0% compared to the previous year. The company’s full-ye
02-04 19:31
